A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients

被引:34
作者
Cho, Sukki [1 ]
Lee, Eung Bae [1 ]
机构
[1] Kyungpook Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Taegu, South Korea
关键词
RECURRENT; MANAGEMENT; F-18-FDG; THERAPY; UTILITY; IMPACT; PET;
D O I
10.1016/j.jtcvs.2009.09.055
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: A follow-up integrated positron emission tomography/computed tomography (PET/CT), as part of a more intensive surveillance program, has been performed at around 1 year after curative resection, regardless of the patients' symptoms or findings in other tests. This study was designed to evaluate the results of this follow-up integrated PET/CT in patients treated for non-small-cell lung cancer without symptoms or abnormal findings. Methods: Between January 2003 and December 2006, this study enrolled 86 patients with non-small cell lung cancer who had no clinical or radiologic evidence of recurrence after curative resection before integrated PET/CT and underwent a follow-up integrated PET/CT around 1 year at our institution. Results: The time from operation to the follow-up integrated PET/CT check was 13.4 +/- 4.4 months. Integrated PET/CT showed negative findings in 41 (47.7%) patients, equivocal findings in 16 (18.6%) patients, and positive findings in 29 (33.7%) patients. Twenty-seven (31.4%) patients had recurrent disease and 2 patients had extra-thoracic double primary cancer. Six patients had extrathoracic recurrence without intrathoracic recurrence. Conclusions: A postoperative follow-up integrated PET/CT can be used for early detection of recurrence in asymptomatic patients who had had resection of non-small-cell lung cancer. Further studies are required to evaluate the cost-effectiveness or survival benefit of follow-up integrated PET/CT. (J Thorac Cardiovasc Surg 2010;139:1447-51)
引用
收藏
页码:1447 / 1451
页数:5
相关论文
共 17 条
[1]
[Anonymous], 1997, Chest
[2]
Does intensive follow-up alter outcome in patients with advanced lung cancer? [J].
Benamore, Rachel ;
Shepherd, Frances A. ;
Leighl, Natasha ;
Pintilie, Melania ;
Patel, Milan ;
Feld, Ronald ;
Herman, Stephen .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (04) :273-281
[3]
PET/CT imaging of lung cancer [J].
Bruzzi, John F. ;
Munden, Reginald F. .
JOURNAL OF THORACIC IMAGING, 2006, 21 (02) :123-136
[4]
Edelman MJ, 1997, J GEN INTERN MED, V12, P318, DOI 10.1046/j.1525-1497.1997.012005318.x
[5]
Hicks RJ, 2001, J NUCL MED, V42, P1605
[6]
INOUE T, 1995, J NUCL MED, V36, P788
[7]
Keidar Z, 2004, J NUCL MED, V45, P1640
[8]
Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer [J].
Lee, Ho-Young ;
Chung, June-Key ;
Jeong, Jae Min ;
Lee, Dong Soo ;
Kim, Dong Gyu ;
Jung, Hee Won ;
Lee, Myung Chul .
ANNALS OF NUCLEAR MEDICINE, 2008, 22 (04) :281-286
[9]
National Comprehensive Cancer Network, 2000, PRACT GUID NONSM CEL
[10]
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003 [J].
Pfister, DG ;
Johnson, DH ;
Azzoli, CG ;
Sause, W ;
Smith, TJ ;
Baker, S ;
Olak, J ;
Stover, D ;
Strawn, JR ;
Turrisi, AT ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :330-353